Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laughton

Showing results (201-210 of 439) with videos related to

Pageof 44
Sort By:
Anti-Cancer Drug Design|August 1, 1990
Structural studies on bio-active compounds. Part XIV. Molecular modelling of the interactions between pentamidine and DNAC E Sansom, C A Laughton, S Neidle, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|May 3, 2002
Peginterferon-alpha-2a (40kD) and ribavirin in patients with chronic hepatitis C: a phase II open-label studyMark Sulkowski, Robert Reindollar, David L Thomas, et al.
Frontiers in Systems Neuroscience|June 20, 2025
Evidence of functional connectivity disruptions between auditory and non-auditory regions in adolescents living with HIVJoanah Madzime, Marcin Jankiewicz, Ernesta M Meintjes, et al.
Journal of Clinical Pharmacology|April 29, 1998
Single-dose pharmacokinetics of modafinil and methylphenidate given alone or in combination in healthy male volunteersY N Wong, S P King, W B Laughton, et al.
Journal of Molecular Graphics & Modelling|May 29, 2007
Modelling the restoration of wild-type dynamic behaviour in DeltaF508-CFTR NBD1 by 8-cyclopentyl-1,3-dipropylxanthineDaniel J Warner, Manish M Vadolia, Charles A Laughton, et al.
The Biochemical Journal|March 1, 1989
The mechanism of initiation of lipid peroxidation. Evidence against a requirement for an iron(II)-iron(III) complexO I Aruoma, B Halliwell, M J Laughton, et al.
Molecular Pharmacology|November 1, 1995
Pharmacological properties of recombinant human N-methyl-D-aspartate receptors comprising NR1a/NR2A and NR1a/NR2B subunit assemblies expressed in permanently transfected mouse fibroblast cellsT Priestley, P Laughton, J Myers, et al.
Developmental and Comparative Immunology|April 30, 2011
Escherichia coli K-12 pathogenicity in the pea aphid, Acyrthosiphon pisum, reveals reduced antibacterial defense in aphidsBoran Altincicek, Bas Ter Braak, Alice M Laughton, et al.
Oncology|April 2, 2010
Acquired resistance to temozolomide in glioma cell lines: molecular mechanisms and potential translational applicationsJihong Zhang, Malcolm F G Stevens, Charles A Laughton, et al.
Developmental Medicine and Child Neurology|August 31, 2016
HIV encephalopathy with bilateral lower limb spasticity: upper limb motor function and level of activity and participationTheresa N Mann, Kirsten A Donald, Barbara Laughton, et al.
Pageof 44

Showing results (201-210 of 439) with videos related to

Sort By:
Pageof 44
Anti-Cancer Drug Design|August 1, 1990
Structural studies on bio-active compounds. Part XIV. Molecular modelling of the interactions between pentamidine and DNAC E Sansom, C A Laughton, S Neidle, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|May 3, 2002
Peginterferon-alpha-2a (40kD) and ribavirin in patients with chronic hepatitis C: a phase II open-label studyMark Sulkowski, Robert Reindollar, David L Thomas, et al.
Frontiers in Systems Neuroscience|June 20, 2025
Evidence of functional connectivity disruptions between auditory and non-auditory regions in adolescents living with HIVJoanah Madzime, Marcin Jankiewicz, Ernesta M Meintjes, et al.
Journal of Clinical Pharmacology|April 29, 1998
Single-dose pharmacokinetics of modafinil and methylphenidate given alone or in combination in healthy male volunteersY N Wong, S P King, W B Laughton, et al.
Journal of Molecular Graphics & Modelling|May 29, 2007
Modelling the restoration of wild-type dynamic behaviour in DeltaF508-CFTR NBD1 by 8-cyclopentyl-1,3-dipropylxanthineDaniel J Warner, Manish M Vadolia, Charles A Laughton, et al.
The Biochemical Journal|March 1, 1989
The mechanism of initiation of lipid peroxidation. Evidence against a requirement for an iron(II)-iron(III) complexO I Aruoma, B Halliwell, M J Laughton, et al.
Molecular Pharmacology|November 1, 1995
Pharmacological properties of recombinant human N-methyl-D-aspartate receptors comprising NR1a/NR2A and NR1a/NR2B subunit assemblies expressed in permanently transfected mouse fibroblast cellsT Priestley, P Laughton, J Myers, et al.
Developmental and Comparative Immunology|April 30, 2011
Escherichia coli K-12 pathogenicity in the pea aphid, Acyrthosiphon pisum, reveals reduced antibacterial defense in aphidsBoran Altincicek, Bas Ter Braak, Alice M Laughton, et al.
Oncology|April 2, 2010
Acquired resistance to temozolomide in glioma cell lines: molecular mechanisms and potential translational applicationsJihong Zhang, Malcolm F G Stevens, Charles A Laughton, et al.
Developmental Medicine and Child Neurology|August 31, 2016
HIV encephalopathy with bilateral lower limb spasticity: upper limb motor function and level of activity and participationTheresa N Mann, Kirsten A Donald, Barbara Laughton, et al.
Pageof 44